| Dr Pedro G Mendoza, MD FCCP | |
|
300 W Century Ave, Bismarck, ND 58503-1401 | |
| (701) 323-9900 | |
| (701) 323-9911 |
| Full Name | Dr Pedro G Mendoza |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 300 W Century Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609825132 | NPI | - | NPPES |
| 15689 | Medicaid | ND | |
| N712611 | Other | ND | MEDICARE SOLO # |
| 12293 | Other | ND | MEDICIAD GROUP NUMBER |
| 22774 | Other | ND | BCBS OF ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 5553 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pedro G Mendoza, MD FCCP 300 W Century Ave, Bismarck, ND 58503-1401 Ph: (701) 323-9900 | Dr Pedro G Mendoza, MD FCCP 300 W Century Ave, Bismarck, ND 58503-1401 Ph: (701) 323-9900 |
News Archive
Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers - the most common cancer in Australian men.
New York City residents are living longer than ever, but our city still faces significant health problems. In a new report, the leading causes of preventable illness and death in New York City are outlined.
Blue Cross Blue Shield of Michigan is being sued for a second time in two weeks for allegedly pressuring hospitals to sign "most favored nation" contracts that required them to charge competing insurers higher rates.
Auxilium Pharmaceuticals, Inc. a specialty biopharmaceutical company, today announced that the United States Patent and Trademark Office issued U.S. Patent No. 7,811,560 claiming, among other things, purified collagenase, the active component in Auxilium's product XIAFLEX (collagenase clostridium histolyticum).
A prominent protein activated by inflammation is the key instigator that converts glioblastoma multiforme cells to their most aggressive, untreatable form and promotes resistance to radiation therapy, an international team lead by researchers at The University of Texas MD Anderson Cancer Center reported online today in the journal Cancer Cell.
› Verified 1 days ago
Dr. Ling Sing Chow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Nicholas C Mahr, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th Street, Bismarck, ND 58501 Phone: 701-530-7500 Fax: 701-530-7484 | |
Dr. Maria Susana Castejon Welchez, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Dr. Sharmaine Habib, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-8121 | |
Agnieszka Olga Solberg, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Amy Marie Kaminski, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Ivaldo A Lunardi, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 |